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Abstract
DJ-1 is a novel oncogene and also causative gene for familial Parkinson’s disease park7. DJ-1 has multiple functions that
include transcriptional regulation, anti-oxidative reaction and chaperone and mitochondrial regulation. For transcriptional
regulation, DJ-1 acts as a coactivator that binds to various transcription factors, resulting in stimulation or repression of the
expression of their target genes. In this study, we found the low-density lipoprotein receptor (LDLR) gene is a transcriptional
target gene for DJ-1. Reduced expression of LDLR mRNA and protein was observed in DJ-1-knockdown cells and DJ-1-
knockout mice and this occurred at the transcription level. Reporter gene assays using various deletion and point mutations
of the LDLR promoter showed that DJ-1 stimulated promoter activity by binding to the sterol regulatory element (SRE) with
sterol regulatory element binding protein (SREBP) and that stimulating activity of DJ-1 toward LDLR promoter activity was
enhanced by oxidation of DJ-1. Chromatin immunoprecipitation, gel-mobility shift and co-immunoprecipitation assays
showed that DJ-1 made a complex with SREBP on the SRE. Furthermore, it was found that serum LDL cholesterol level was
increased in DJ-1-knockout male, but not female, mice and that the increased serum LDL cholesterol level in DJ-1-knockout
male mice was cancelled by administration with estrogen, suggesting that estrogen compensates the increased level of
serum LDL cholesterol in DJ-1-knockout female mice. This is the first report that DJ-1 participates in metabolism of fatty acid
synthesis through transcriptional regulation of the LDLR gene.
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Introduction
The DJ-1 gene has been identified by us as a novel oncogene
that transforms NIH3T3 cells in cooperation with the activated ras
gene [1] and was later found to be a causative gene for familial
Parkinson’s disease park7 [2]. DJ-1 is expressed ubiquitously in
cultured cells and tissues and is localized in the cytoplasm, nucleus
and mitochondria [1,3–6]. DJ-1 has multiple functions, including
transcriptional regulation [7–15], anti-oxidative stress function
[3,16–20], chaperone [4,21], protease [22–24] and mitochondrial
regulation [25–28]. DJ-1 binds to various signaling proteins such
as PTEN [29,30], ASK1 [31,32], HIPK1 [33] and Daxx [34] to
affect their signaling cascades, leading to progression of cell growth
and inhibition of cell death. For its role in transcriptional
regulation, DJ-1 binds to various transcription factors, including
inhibitors for androgen receptor [7,8], p53 [9,14], polypyrimidine
tract-binding protein-associated splicing factor (PSF) [10] and
Keap1, an inhibitor for nuclear factor erythroid-2 related factor 2
(Nrf2) [11], to modulate their transcriptional activity, resulting in
various effects on cell functions. It is therefore thought that loss of
and excess activation of DJ-1 render the onset of neurodegener-
ative diseases such as Parkinson’s disease and cancer, respectively.
We previously searched for genes whose expression was
changed in DJ-1-knockdown cells compared to that in parental
cells by using a DNA microarray, and we identified many
candidate genes, including the low-density lipoprotein receptor
(LDLR) gene [35]. LDLR is cell surface protein involved in
receptor-mediated endocytosis of a specific ligand, low-density
lipoprotein (LDL). LDL is then transferred into the lysosome,
where it is degraded and cholesterol is produced by microsomal
enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA)
reductase. The level of LDLR is related to pathogenesis of lipidosis
and type 2 diabetes mellitus, and mutations in the LDLR gene
cause the autosomal dominant disorder familial hypercholesterol-
emia. Expression of the LDLR gene is activated by sterol regulatory
element binding protein (SREBP), which binds to the sterol
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e38144regulatory element (SRE) on the LDLR gene promoter in
cooperation with Sp1 [36–39]. The SRE is also present in genes
for HMG CoA reductase and HMG CoA synthetase and acts as a
positive element that responds to reduction of the cholesterol level
in cells. It is also known that estrogen stimulates the promoter
activity of the LDLR promoter [40].
In this study, we found using a cell culture system and DJ-1-
knockout mice that DJ-1 stimulates expression of the LDLR gene at
the transcriptional level by association with SREBP and affects the
level of serum LDL cholesterol in male mice.
Results
Reduced Expression of Low-density Lipoprotein Receptor
Gene in Dj-1-Knodown Cells and Knockout Mice
We have screened genes whose expression was reduced in D2
cells, which are DJ-1-knocked down NIH3T3 cells, compared to
that in parental NIH3T3 cells by using a DNA microarray, and
the low-density lipoprotein receptor (LDLR) gene was found to be
a candidate gene [35]. To confirm this, total RNA was extracted
from D2 and NIH3T3 cells and the expression levels of LDLR,
DJ-1 and actin mRNA were examined by semi-quantitative RT-
PCR (data not shown) and by quantitative real-time PCR. Actin
mRNA was used as a loading control. As shown in Figure 1A, the
expression levels of LDLR and DJ-1 mRNAs in D2 cells were
reduced to about 60% of those in NIH3T3 cells. To examine
whether reduced expression of LDLR mRNA occurs in mice,
RNA was extracted from the liver of DJ-1-knockout and normal
mice at 25 weeks and 36 weeks of age and quantitative real-time
PCR was carried out. As in the case of D2 cells, about 50% and
30% reduction of LDLR mRNA expression was found in DJ-1-
knockout mice at 25 weeks and 36 weeks of age, respectively.
Furthermore, liver cell lines from DJ-1-knockout and normal mice
were established after liver cells from newborn male mice had
been immortalized by SV40 T antigen, and the expression level of
their mRNA was examined by quantitative real-time PCR. Again,
reduced expression of LDLR mRNA was found in DJ-1-knockout
cells. Expression levels of LDLR and DJ-1 in NIH3T3 and D2
cells and in the liver from DJ-1-knockout mice were then
examined by Western blotting. Three bands corresponding to
LDLR were observed in NIH3T3 and these bands are known to
be differentially glycosylated LDLR. Although intensity of all of
the three bands was reduced in D2 cells, a band with 130 kDa was
almost disappeared (Figure 1B). Only a band of LDLR with
130 kDa was, on the other hand, observed in the liver of mice at
various ages, and the result of mice at 25 weeks of age was shown
(Figure 1C, left panel). As in the case of mRNA levels, reduced
levels of LDLR were found in DJ-1-knockout mice at 13 weeks
and 51 weeks of age (Figure 1C, right panel).
The expression levels of LDLR and DJ-1 were further examined
by an immunostaining method. Liver cell lines and liver sections
from DJ-1 (+/+) and DJ-1 (2/2) mice were stained with anti-
LDLR and anti-DJ-1 antibodies. Nuclei were also stained with
DAPI. As shown in Figure 2, the expression levels of LDLR in
liver cells and in liver from DJ-1 (2/2) mice were significantly
reduced. These results indicate that reduced or no expression of
DJ-1 rendered reduced expression of the LDLR gene.
Stimulation of LDLR Promoter Activity by DJ-1
To examine the effect of DJ-1 on LDLR gene promoter activity,
the upstream region of the LDLR gene spanning 24000 to +57
linked to the luciferase gene (pGL4.10-hLDLR 200) [41] was
transfected into D2 and NIH3T3 cells and its luciferase activity
was measured. The upstream region used contains two important
elements, LXRE and SRE (Figure 3A). As shown in Figure 3B,
luciferase activity in D2 cells was reduced to 58% compared to
that in NIH3T3 cells, suggesting that promoter activity of the
LDLR gene was attenuated in DJ-1-knockdown cells. To further
assess the effect of DJ-1 on LDLR promoter activity, D2 cells were
transfected with pGL4.10-hLDLR 200 together with various
amounts of expression vectors for wild-type DJ-1, C106S and
L166P mutants of DJ-1, and the luciferase activity was measured
(Figure 3C). C106S and L166P mutants of DJ-1 are substitution
mutants from cysteine at amino acid number 106 (C106) to serine
and from leucine at amino acid number 166 to proline,
respectively. Since C106 of DJ-1 is the most sensitive amino acid
residue toward oxidative stress and an essential amino acid for DJ-
19s function, C106S DJ-1 has no or little activity [2,4,16]. L166P
DJ-1 has been found in patients with familial Parkinson’s disease
[2]. The results showed that while wild-type DJ-1 stimulated
luciferase activity in a dose-dependent manner, neither C106S nor
L166P mutants of DJ-1 stimulated luciferase activity, suggesting
that stimulation of LDLR promoter activity needs a wild-type
conformation of DJ-1 and that oxidative stress affects stimulating
activity toward the LDLR promoter.
To address the effect of oxidative stress on DJ-1-stimulated
LDLR promoter activity, NIH3T3 and D2 cells were transfected
with pGL4.10-hLDLR 200. At 48 hrs after transfection, cells were
exposed to various concentrations of H2O2 for 1 hr together with
or without N-acetylcysteine (NAC), an antioxidant, and their
luciferase activity was measured (Figure 3D). Luciferase activity in
NIH3T3 cells was increased up to 50 mMH 2O2 in a dose-
dependent manner and then decreased at 100 and 250 mMH 2O2
exposure. These effects of H2O2 on luciferase activity were not
observed in NIH3T3 cells that had been treated with NAC. In D2
cells exposed to 0–250 mMH 2O2, on the other hand, no
stimulation of luciferase activity was observed regardless of the
presence or absence of NAC. Stimulation curve of luciferase
activity in H2O2-treated NIH3T3 cells is similar to that observed
in DJ-1-activated tyrosine hydroxylase promoter activity in H2O2-
treated SH-SY5Y cells as described previously [13]. In this case,
oxidative status of C106 of DJ-1 determined the stimulation level
of tyrosine hydroxylase promoter activity by DJ-1 [13]. Further-
more, D2 cells were transfected with pGL4.10-hLDLR 200
together with expression vectors for wild-type DJ-1 and C106S
mutant of DJ-1. At 48 hrs after transfection, cells were exposed to
100 mMH 2O2 and the luciferase activity was measured
(Figure 3E). The results showed that luciferase activity was
increased by wild-type DJ-1 and further increased by H2O2
exposure. The effect of C106S DJ-1 on luciferase activity was
weaker than that of wild-type DJ-1, and no stimulation by C106S
DJ-1 was observed after cells were exposed to H2O2. These results
suggest that stimulation of LDLR promoter activity by H2O2
exposure depends on oxidative status of C106 of DJ-1, but not on
simple oxidation to cells.
To determine the region targeted by DJ-1, various deletion
constructs of the LDLR promoter linked to the luciferase gene were
constructed and they were transfected into D2 cells with or
without an expression vector for DJ-1. As shown in Figure 4,
various deletions up to 2225 from a transcriptional start site
similarly reacted to DJ-1, suggesting that the region 2225 to +57
contains the DJ-1-responsive region. Since LDLR gene expression
has been reported to be regulated by two elements, the sterol
regulatory element (SRE) and liver X receptor response element
(LXRE), and the region 2225 to +57 contains the SRE
[36,37,41], the reporter construct containing either mutation of
SRE or LXRE was transfected into D2 cells. The results showed
that while LXRE mutation did not affect the response to DJ-1,
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suggesting that the SRE is a target site for DJ-1.
Association of DJ-1 with the Sterol Regulatory Element
SREBP-1 and SREBP-2 are proteins that bind to the SRE. To
examine the association of DJ-1 with the SRE, chromatin
immunoprecipitation assays were carried out. Chromatin extract-
Figure 1. Reduction of LDLR gene expression in DJ-1-knockdown cells and DJ-1-knockout mice. A. Relative mRNA levels of LDLR were
examined by quantitative RT-PCR (real-time PCR) in NIH3T3 and its DJ-1-knockdown D2 cells, in livers from wild-type and DJ-1-knockout mice at 25
and 36 weeks of age and in the established liver cell line from wild-type and DJ-1-knockout mice. Actin or GAPDA mRNA was also amplified by real-
time PCR as loading controls. Statistical analyses were carried out using Student’s t-test. Number of experiments (n) is 3. B and C. Proteins extracted
from NIH3T3 and D2 cells (B) and from livers of wild-type and DJ-1-knockout mice at 13 and 51 weeks of age (right panels in C) were analyzed by
Western blotting with anti-LDLR, anti-DJ-1 and b-actin antibodies. b-actin was used as a loading control. Proteins from the liver of wild-type mouse at
25 weeks of age were analyzed by Western blotting with an anti-LDLR antibody (left panel in C).
doi:10.1371/journal.pone.0038144.g001
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DJ-1, anti-SREBP-1 and anti-SREBP-2 antibodies, and two
regions spanning 23,920 to 23,664 and spanning 2180 to +54
were amplified by real-time PCR with specific primers and with
precipitated DNA as a template. As shown in Figure 5A-a, anti-
DJ-1, anti-SREBP-1 and anti-SREBP-2 antibodies but not IgG
specifically precipitated the region spanning 2180 to +54 and
small amounts of amplification in the region spanning 23,920 to
23,664 were observed, indicating that DJ-1, SREBP-1 and
SREBP-2 bound to this region. Chromatin immunoprecipitation
assays were also carried out using chromatin extracted from DJ-1-
knockdown D2 cells (Figure 5A-b). The results showed that anti-
Figure 2. Reduction of LDLR expression in DJ-1-knockout cells and in DJ-1-knockout mice. A. Mouse liver cells from wild-type and DJ-1-
knockout mice were immunostained with anti-LDLR and anti-DJ-1 antibodies. The cells were then reacted with an FITC-conjugated anti-rabbit IgG or
with a rhodamine-conjugated anti-rabbit IgG for 1 hr, and their nuclei were stained with DAPI. The cells were then observed under a fluorescent
microscope as described in Materials and methods. B. Liver sections from wild-type and DJ-1-knockout mice were immunostained with anti-LDLR and
anti-DJ-1 antibodies and visualized after reaction with an FITC-conjugated anti-rabbit IgG as described in Materials and methods. Nuclei were also
stained with DAPI.
doi:10.1371/journal.pone.0038144.g002
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e38144SREBP-1 and anti-SREBP-2 antibodies, but not the anti-DJ-1
antibody, precipitated the region spanning 2180 to +54 and that
the levels of precipitated DNA from D2 chromatin were lower
than those from NIH3T3 chromatin. Gel photos showing the final
PCR products are also shown in Figure S1.
To further assess the binding of DJ-1 with the SRE, gel-mobility
shift assays were carried out using nuclear extracts from mouse
liver cells and Cy5.5-labeled SRE as a probe. DNA-protein
complex was found on the SRE, and a shifted band on the SRE
disappeared after addition of excess amounts of non-labeled SRE
oligonucleotide but not mutated oligonucleotide (Figure 5B-a),
indicating that DNA-protein complex was specific to the SRE.
After addition of non-specific IgG or anti-DJ-1, anti-SREBP-1 and
anti-SREBP-2 antibodies to reaction mixtures, the specific band
was supershifted with anti-DJ-1 and anti-SREBP-2 antibodies but
not with IgG and with an anti-SREBP-1 antibody (Figure 5B-b).
Supershift assays were also carried out using human SH-SY5Y
nuclear extracts, and anti-DJ-1 and anti-SREBP-2 antibodies but
not the anti-SREBP-1 antibody supershifted a band of the SRE-
protein complex (Figure 5B-c). Different mobility of the band
supershifted by the anti-SREBP-2 antibody in liver and SH-SY5Y
cells may be different origins of two cell limes. These results
indicate that protein complexes containing DJ-1, SREBP-1 and
SREBP-2 bind to the SRE. To examine direct interaction of DJ-1
with SREBP1 or SREBP2, pull-down experiments were carried
out. GST-DJ-1 purified from E. coli was reacted with
35S-labeled
SREBP-1 or SREBP-2, which had been synthesized using a
reticulocyte lysate in vitro. The results showed that neither SREBP-
2 nor SREBP-1 directly bound to DJ-1 (Figure S2). Gel-mobility
shift assays were then carried out using recombinant human DJ-1
and Cy5.5-labeled wild-type SRE and LXRE as probes, and the
result using an SRE probe was shown (Figure S3). No binding of
DJ-1 to the SRE was observed.
Since DJ-1 does not directly bind to DNA (Figure S3) and since
it has been reported that SREBP-1/SREBP-2 directly binds to the
SRE and that SREBP-2 and SREBP-1 make heterodimer [42], it
is possible that DJ-1 binds to the SRE in association with SREBP-
1/SREBP-2 via unknown protein(s). To examine this possibility,
Figure 3. Stimulation of promoter activity of the LDLR gene by DJ-1. A. Schematic drawing of the reporter gene comprised of the LDLR
promoter and the luciferase gene. B. NIH3T3 and D2 cells in 24-well dishes were transfected with 0.75 mg of pGL4.10-hLDLR and 0.25 mg of pCMV-b-
gal. Forty-eight hrs after transfection, cell extracts were prepared and their luciferase activity was measured as described in Materials and methods.
Statistical analyses were carried out using Student’s t-test. Number of experiments (n) is 3. C. D2 cells in a 6-well dish were transfected with 0.75 mgo f
pGL4.10-hLDLR and 0.25 mg of pCMV-b-gal together with 0.25, 0.75 and 1.0 mg of pEF-DJ-1-HA (wild-type, C106 and L166 mutants of DJ-1). Forty-
eight hrs after transfection, cell extracts were prepared and their luciferase activity was measured as described in Materials and methods. The
expression level of DJ-1-HA and actin in cell extracts was analyzed by Western blotting with an anti-HA antibody. Number of experiments (n) is 4. D.
NIH3T3 and D2 cells in a 6-well plat were transfected with 0.75 mg of pGL4.10-hLDLR and 0.25 mg of pCMV-b-gal. At 48 hrs after transfection, cells
were exposed to various concentration of H2O2 together to 2 mM N-acetylcysteine for 1 hr and their luciferase activity was measured. Number of
experiments (n) is 4. E. D2 cells in a 6-well dish were transfected with 0.75 mg of pGL4.10-hLDLR and 0.25 mg of pCMV-b-gal together with 1.0 mgo f
pEF-DJ-1-HA (wild-type and C106). Forty-eight hrs after transfection, cells were exposed to 100 mMH 2O2 for 1 hr and their luciferase activity was
measured. The expression level of DJ-1 in cell extracts was analyzed by Western blotting with an anti-HA antibody. Number of experiments (n) is 4.
Statistical analyses in Figure 6C, 6D and 6E were carried out using the Tukey-Kramer test.
doi:10.1371/journal.pone.0038144.g003
Figure 4. Identification of the target region for DJ-1 in the LDLR promoter. Various deletion constructs of the LDLR promoter linked to the
luciferase gene were constructed and transfected into D2 cells together with pEF or pEF-DJ-1-HA as described in the legend of Figure 2. Forty-eight
hrs after transfection, luciferase activity was measured. Statistical analyses were carried out using Student’s t-test. Number of experiments (n) is 3.
doi:10.1371/journal.pone.0038144.g004
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immunoprecipitated with an anti-DJ-1 antibody or non-specific
IgG and precipitates were analyzed by Western blotting with anti-
SREBP-1, anti-SREBP-2 and anti-DJ-1 antibodies. SREBP-1 and
SREBP-2 are known to be cleaved from precursor forms to be
activated. As shown in Figure 6A and 6B, the anti-DJ-1 antibody
Figure 5. Association of DJ-1 and SREBP with the LDLR promoter. A. Chromatin immunoprecipitation assays were carried out using
chromatin prepared from NIH3T3 (a) and D2 (b) cells. Chromatin was immunoprecipitated with anti-DJ-1, anti-SREBP-1 and anti-SREBP-2 antibodies or
non-specific IgG. After extraction of DNA from precipitated chromatin, two regions spanning 2180 to +54 and spanning 23920 to +54 were
amplified by real-time PCR with specific primers and with amplified DNA as described in Materials and methods. Statistical analyses were carried out
using Student’s t-test. Number of experiments (n) is 3. B. Gel-mobility shift assays were carried out using nuclear extracts from mouse liver and SH-
SY5Y cells with IRDye800-labeled SRE oligonucleotide as a probe. a. NIH3T3 nuclear extracts were mixed with 50 and 100-times molar ratio of wild-
type and mutated oligonucleotide compared to that of IRDye800-labeled SRE and subjected to gel-mobility shift assays. b and c. Mouse liver cell (b)
or D2 cell (c) nuclear extracts were first reacted with the IRDye800-labeled SRE probe for 30 min at 0uC and then with an anti-DJ-1 antibody, anti-
SREBP-1 antibody, anti-SREBP-2 antibody or IgG, and then separated on 4% polyacrylamide gel as described in Materials and methods.
doi:10.1371/journal.pone.0038144.g005
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e38144Figure 6. Association of DJ-1 with SREBP-2 and involvement of DJ-1 in LDLR expression. A and B. Proteins in mouse liver cell (A) or SH-
SY5Y cell (B) nuclear extracts were immunoprecipitated with an anti-DJ-1 antibody or IgG. Immunoprecipitates were then analyzed by Western
blotting with anti-SREBP-1, anti-SREBP-2 and anti-DJ-1 antibodies. PreSREBP-2 and preSREPB-1 indicate precursor SREBP-2 and precursor SREPB-1, and
nSREBP-2 and nSREPB-1 indicate cleaved SREBP-2 and cleaved SREPB-1, respectively. C. NIH3T3 and D2 cells were transfected with siRNAs targeting
DJ-1, SREBP-1 and SREBP-2 and with non-specific siRNA. At 48 hrs after transfection, expression levels of LDLR and actin mRNA were examined by
real-time PCR and relative expression of LDLR against actin was shown. Statistical analyses were carried out using the Tukey-Kramer test.
doi:10.1371/journal.pone.0038144.g006
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those of SREBP-1, indicating association of DJ-1 with SREBP-2.
To confirm roles of DJ-1, SREBP1 and SREBP2 in transcrip-
tional activation of the LDLR gene, NIH3T3 cells were
transfected with siRNAs targeting DJ-1, SREBP-1 and SREBP-2
and with non-specific siRNA, and the expression level of LDLR
mRNA was examined by real-time PCR at 48 hrs after
transfection. As shown in Figure 6C, siRNAs for DJ-1 and
SREBP-2, but not for SREBP-1, significantly reduced expression
levels of LDLR mRNA. Furthermore, when DJ-1-knockdown D2
cells were transfected with siRNAs targeting SREBP-1 and SREBP-
2 and with non-specific siRNA, the expression levels of LDLR
mRNA were not significantly affected. These results suggest that
the DJ-1/SREBP-2 complex binds to the SRE on the LDLR
promoter to activate its promoter activity and that SREBP-1 also
binds to the SRE without complex formation with DJ-1. Since the
binding level of SREBP-1 to the LDLR promoter is reduced in DJ-
1-knockdown cells, DJ-1 may affect binding activity of SREBP-1
by unknown mechanism.
Serum Cholesterol Levels in DJ-1-knockout Mice
Since the expression level of LDLR is related to pathogenesis of
lipidosis and type 2 diabetes mellitus and since DJ-1 regulates the
LDLR expression as described above, the effect of DJ-1 on
cholesterol levels was examined using DJ-1-knockout mice. First,
the total cholesterol amounts in serum from wild-type and DJ-1-
kickout mice were measured. The total cholesterol levels of male
and female mice at 25 and 40 weeks of age tended to increase with
age, but there were no significant difference between wild-type and
DJ-1-knockout mice regardless of age or sex (Figure 7A). Next, the
serum LDL cholesterol level was examined. Although the serum
LDL cholesterol level in female mice at 25 and 40 weeks of age
was not significantly changed between wild-type and DJ-1-
knockout mice, it was found that the level in male mice was
significantly increased in DJ-1-knockout mice at both ages
compared to that in wild-type mice (Figure 7B), suggesting that
DJ-1 affects metabolism of LDL cholesterol in male mice. To
explain different effects of DJ-1 inactivation on serum LDL
cholesterol levels in male and female mice, estrogen was
administered to DJ-1-knockout male mice at 25 and 40 weeks of
age and serum LDL cholesterol levels were measured. Wild-type
male mice at 25 weeks of age were also administered estrogen as a
negative control. As shown in Figure 7C, there were no significant
differences of serum LDL cholesterol levels in DJ-1-knockout male
mice at both ages with or without administration of estrogen.
These results suggest that estrogen is one of factors that influence
the effect of DJ-1 on the serum LDL cholesterol level. It has been
reported that when LDLR-knockout mice were fed with a high-
cholesterol diet, they had a three-fold higher concentration of the
serum LDL cholesterol than that in mice fed with an ordinary diet,
resulting in atherosclerosis [43]. To examine the effect of diets on
the serum LDL cholesterol level of DJ-1-kockout mice, wild-type
and DJ-1-kockout male mice at 13 weeks of age were fed with a
high-cholesterol diet, and their serum LDL cholesterol levels were
measured. While the serum LDL cholesterol level of wild-type
mice was increased after mice were fed with the high-cholesterol
diet, no significant change was observed in DJ-1-knockout mice.
These results suggest the specific effects of DJ-1 in cholesterol
homeostasis.
Discussion
In this study, we first found that DJ-1 positively regulates LDLR
gene expression at the transcriptional level through association of
SREBP on the SRE located in the LDLR promoter. Reduced
expression of the LDLR gene was observed in DJ-1-knockdown
cells, DJ-1-knockout cells and DJ-1-knockout mice. We then found
that the serum LDL cholesterol level is increased in DJ-1-knockout
male mice compared to that in wild-type mice. This is the first
finding of participation of DJ-1 in cholesterol metabolism.
Deletion and point mutation analysis of the LDLR promoter
showed that of two known elements, LXRE and SRE, which are
important for LDLR expression [36,37,41], the SRE was found to
be a target for DJ-1. SREBP-1 and SREBP-2 recognize the same
sequence of the SRE (see a recent review 43, original references
therein). While SREBP-2 is ubiquitously expressed in tissues,
SREBP-1 is preferentially expressed in the liver and adrenal gland
[44]. Although chromatin immunoprecipitation (ChIP) assays
using NIH3T3 and its DJ-1 knockdown D2 chromatin showed
that anti-DJ-1, anti-SREBP-1 and anti-SREBP-2 antibodies
precipitated the region containing the SRE (Figure 5A), gel-
mobility shift and co-immunoprecipitation assays using mouse
liver and SH-SY5Y cell extracts showed that anti-DJ-1 and anti-
SREBP-2 antibodies, but not an anti-SREBP-1 antibody, super-
shifted a band corresponding to the SRE-protein complex and that
DJ-1 is associated with SREBP-2 but not with SREBP-1 (Figure 5B
and 6, respectively). Direct interaction of DJ-1 with SREBP2 and
SREBP-1 was not observed in pull-down assays (Figure S2). DJ-1
does not directly bind to DNA (Fig. S3), and SREBP-1/SREBP-2
directly binds to the SRE [42]. siRNAs targeting SREBP-2 and
SREBP-1 do not significantly reduce the expression level of LDLR
mRNA in DJ-1-knockdown D2 cells (Figure 6C). These results
suggest that the DJ-1/SREBP-2 complex binds to the SRE on the
LDLR promoter to activate its promoter activity and that SREBP-
1 also binds to the SRE without complex formation with DJ-1.
Since the binding level of SREBP-1 to the LDLR promoter was
reduced in DJ-1-knockdown cells (Figure 5A-b), DJ-1 may affect
binding activity of SREBP-1 by unknown mechanism.
Stimulating activity of DJ-1 toward the LDLR promoter also
depends on oxidative stress in cells expressing the normal level of
DJ-1 (Figure 3D). LDLR promoter activity in NIH3T3 cells
showed a biphasic pattern during course of H2O2 exposure: first
increase and then decrease of activity, and this pattern is not
observed in D2 cells. Furthermore, wild-type DJ-1 but not C106S
DJ-1 activated LDLR promoter activity in an oxidative stress-
dependent manner (Figure 3E). These results suggest that the
oxidative status of C106 of DJ-1 affects LDLR promoter activity as
in the case of DJ-1-activating tyrosine hydroxylase promoter
activity [13].
Since SREBP-2 is a positive regulator for genes related to
cholesterol metabolism, it would be interesting if the complex of
DJ-1 with SREBP-2 also regulates transcription of other genes
related to cholesterol metabolism. In microarray experiments, we
have identified a gene encoding 24-dehydrocholesterol reductase
(Dhcr24) whose expression was reduced in DJ-1-knockdown cells
[35]. Since an SRE-like sequence is present in the promoter region
of the Dhcr24 gene, it is possible that the DJ-1/SREBP-2 complex
positively regulates Dhcr24 expression, too.
In a latter part, we found that the total cholesterol level is not
changed between wild-type and DJ-1-knockout mice regardless of
gender or age. Since the total cholesterol level of wild-type mice is
known to be in the range of 80–120 mg/dl [45–47] and that of
DJ-1-knockout mice was within this range (Figure 7A), it is thought
that DJ-1 expression does not affect the total cholesterol level. The
serum LDL cholesterol level in DJ-1-knockout male mice was,
however, significantly increased compared to that in wild-type
male mice and there was no significant change in DJ-1-knockout
female mice (Figure 7B), suggesting that DJ-1 participates in
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reason for the significant increase of serum LDL cholesterol level
in DJ-1-knockout male mice may be as follows. First, the reduced
level of DJ-1 inhibits transcription of the LDLR gene and renders
the low level of LDLR as shown in Figure 1, resulting in inhibition
of uptake of LDL, thereby increasing the serum LDL cholesterol
level (Figure 8A). Second, endoplasmic reticulum (ER) stress
induces the expression of transcription factor XBP1, which
stimulates the expression of enzymes for fatty acid synthesis,
including diacetylglicerol transferase-2 (Dagt2), stearyl CoA
desaturase (scd1), acetyl CoA carboxylase (Acc2) and fatty acid
synthase (Fasn). When these enzymes are lacking, serum LDL
cholesterol level decreases [48]. Since DJ-1 represses ER stress
[49], reduced or no expression of DJ-1 stimulates the expression of
XBP1, thereby increasing serum LDL cholesterol level (Figure 8B).
Third, it has been reported that several proteins harboring anti-
oxidative activity lower the LDL cholesterol level [50–53]. Since
DJ-1 has anti-oxidative stress function, reduced or no expression of
DJ-1 may increase serum LDL cholesterol level (Figure 8C).
The effect of estrogen might explain why the serum LDL
cholesterol level is not changed in DJ-1-knoout female mice.
Estrogen increases the clearance of LDL cholesterol and then
Figure 7. Total cholesterol and LDL levels in wild-type and DJ-1-knockout mice. A. Total cholesterol levels in wild-type and DJ-1-knockout
mice at 25 and 40 weeks of age were measured by using a cholesterol E kit (Wako Pure Chemical). Number of experiments (n) is 5. B. LDL cholesterol
levels in wild-type and DJ-1-knockout mice at 25 and 40 weeks of age were measured by using an LDL-C.M. kit (Wako Pure Chemical). Number of
experiments (n) is 5–7. C. DJ-1-knockout male mice at 25 and 40 weeks of age and wild-type male mice at 25 weeks of age were administered 5 mg/g
body weight of estradiol for every 6 days, and their LDL cholesterol levels were measured. Number of experiments (n) is 4–7. D. Wild-type and DJ-1-
knockout mice at 13 weeks of age were fed with a high-cholesterol diet, and their serum LDL cholesterol levels were measured as described above.
Number of experiments (n) is 4–7. Statistical analyses of Figs. 7A-7D were carried out using Student’s t-test.
doi:10.1371/journal.pone.0038144.g007
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stimulates promoter activity of the LDLR gene [40]. It is therefore
thought that estrogen compensates the increased level of serum
LDL cholesterol that was induced by DJ-1 knockout in female
mice. Indeed, when DJ-1-knockout male mice were administered
estrogen, the increased serum LDL cholesterol level in male mice
was cancelled (Figure 7C). It has been reported that when LDLR-
knockout mice were fed with a high-cholesterol diet, they had a
three-fold higher concentration of the serum LDL cholesterol than
that in mice fed with an ordinary diet, resulting in atherosclerosis
[43]. Since the expression level of LDLR in DJ-1-knockout mice is
lower than that in wild-type mice (Figure 1C), it is simply thought
that the serum LDL cholesterol level of DJ-1-knockout mice is
increased when DJ-1-knockout mice are fed with the high-
cholesterol diet. While the serum LDL cholesterol level in wild-
type mice was increased, there was no change of the serum LDL
cholesterol level in DJ-1-knockout mice that had been fed with the
high-cholesterol diet (Figure 7D). These results suggest that
although DJ-1 significantly affects cholesterol homeostasis, there
are many factors contributing to DJ-19s effect on cholesterol
homeostasis.
The DJ-1 gene is the causative gene for familial Parkinson’s
disease park7. It has been reported that the lower serum LDL
cholesterol levels are associated with the onset of Parkinson’s
disease [57–59]. The results in this study seem to be contradictory
to those obtained by the cohort study of human cases as described
above. Since DJ-1-knockout mice themselves do not show
phenotypes of Parkinson’s disease [60], some compensation
mechanisms might occur, thereby decreasing the effect of serum
LDL cholesterol levels on the onset of Parkinson’s disease. It has
been reported that simvastatin is associated with reduced
incidence of dementia and Parkinson’s disease [61]. Simvastatin
is a statin-related drug, and statins (3-hydroxy-3-methylglutaryl-
coenzyme A reductase inhibitors) are a class of medications that
reduce cholesterol by inhibiting 3-hydroxy-3-methylglutaryl-coen-
zyme A reductase. It would therefore be interesting to further
analyze the effect of DJ-1 on metabolism of fatty acid.
Materials and Methods
Cells and Mice
NIH3T3 cells were purchased from American Tissue culture
collection (ATCC). DJ-1-knockdown NIH3T3 (D2) cells described
previously [62] and parental NIH3T3 cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) with 10% calf
serum. DJ-1-knockout mice and normal mice were housed as
described previously [60]. Originally established DJ-1-knockout
mice were back-crossed more than 15 tomes and their genotype is
now C57BL/6 background. C57BL/6 mice were used as control
mice with DJ-1 (+/+), and all of the mice were basically fed with
normal diet (D12337, Research Diets, Inc. New Brunswick, NJ).
Liver cell lines from DJ-1-knockout and normal mice were
established as follows. Livers from newborn mice were cut out,
digested with trypsin, and seeded on a 10-cm dish in DMEM with
10% calf serum. Cells were then transfected with an expression
vector for T antigen of simian virus 40 (SV40), pMTI [63]. About
two weeks after transfection, immortalized cells appeared and were
cloned. All animal experiments were carried out in accordance
with the National Institutes of Health Guide for the Care and Use
of Laboratory Animals, and the protocols were approved by the
Committee for Animal Research at Hokkaido University (the
permit number 08–0468).
RT-PCR
Nucleotide sequences of primers used for RT-PCR were as
follows: mGAPDH 655-637: 59-TGACCTTGCCCA-
CAGCCTT-39, mGAPDH 200-219: 59-TCAACGGGAACGG-
GATCACC-39, F-mLDLR: 59-TGTGAATTTGGTGGCT-
Figure 8. Model of increased serum LDL cholesterol in DJ-1-
knockout mice.
doi:10.1371/journal.pone.0038144.g008
Transcriptional Regulation of LDLR by DJ-1
PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e38144GAAAAC-39, R-mLDLR: 59-AATAGGGAAGAAGATGGA-
CAGGAAC-39, mDJ-1 F: 59-GCTTCCAAAA-
GAGCTCTGGTCA-39, and mDJ-1 R: 59-GCTCTAGTCTTT-
GAGAACAAGC-39. Total RNAs were prepared from cells or
mouse tissues and subjected to semi-quantitative RT-PCR
analyses. PCR conditions were as follows: 1 min at 94uC,
30 sec at 94uC, 30 sec at 60uC and 22 cycles of 1 min at 72uC
for GAPDH; 1 min at 94uC, 30 sec at 94uC, 30 sec at 60uC and
29 cycles of 1 min at 72uC for LDLR; and 1 min at 94uC, 30 sec
at 94uC, 30 sec at 58uC and 26 cycles of 1 min at 72uC for DJ-1.
After reactions, PCR products were extracted, separated on 1.4%
agarose gels, and stained with ethidium bromide.
Real-time PCR
Nucleotide sequences of primers used for real-time PCR were as
follows: mLDLR-F: 59-GAACTCAGGGCCTCTGTCTG-39,
mLDLR-R: 59-AGCAGGCTGGATGTCTCTGT-39, ACTB
412F: 59-CCCTAAGGCCAACCGTGAAA-39, ACTB 520R:
59-ACGACCAGAGGCATACAGGGA-39. Quantitative RT-
PCR (real-time PCR) analyses were carried out as described
previously [64].
Luciferase Activity
Nucleotide sequences of oligonucleotides used for PCR
primers to construct deletion mutants of promoter are as follows:
Reverse LDLR: 59-GGCCATGGTCACGACCTGCTGTG-39,
LDLR 225: 59-GGAAGCTTAGCTCTTCACCGGCG-39,
LDLR 418: 59-GGAAGCTTGTGGCGGAAGTTCCC-39,
LDLR897: 59-GGAAGCTTCAGCCCTGTGTGGGG-39,
LDLR 1485: 59-GGAAGCTTATCTGTCCAAGGCCG-39,
LDLR 1985: 59-GGAAGCTTCGTTGCAGCAGCTCC-39,
LDLR 2944: 59-GGAAGCTTCACTGCAAGCTCCGC-39,
and LDLR 3511: 59-GGAAGCTTCTGCGCCACCACGCCT-
39. PCR products were digested with HindIII and NcoI and
inserted into HindIII and NcoI sites of pGL4.10[luc2] (Promega,
Madison, WI, USA). NIH3T3 and D2 cells in 24-well dishes
were transfected with 0.75 mg of pGL4.10-hLDLR 200 or its
deletion reporter plasmids and various amounts (0–1.0 mg) of
pEF-DJ-1-HA together with 0.25 mg of pCMV-b-gal by the
calcium phosphate method [65]. Two days after transfection,
whole cell extract was prepared by addition of Triton X-100-
containing solution from the Pica gene kit (Wako Pure
Chemicals, Osaka, Japan) to the cells. About a one-fifth volume
of the extract was used for the b-galactosidase assay to normalize
the transfection efficiencies as described previously [7], and the
luciferase activity due to the reporter plasmid was determined
using a luminometer (Luminocounter Lumat LB 9507, EG & G
Berthold, Bad Wildbad, Germany). Proteins in aliquots of the cell
extract were analyzed by Western blotting with an anti-FLAG
antibody (M2, Sigma, St. Louis, MO, USA) and visualized as
described in the ‘‘Western blotting and antibody’’ section. The
same experiments were repeated at least three times.
Chromatin Immunoprecipitation (ChIP) Assay
ChIP assays using cultured NIH3T3 cells were performed
according to the protocol of the ChIP Assay Kit (Millipore,
Billerica, MA, USA). Briefly, after proteins had been cross-linked
with DNA, cell pellets were resuspended in an SDS-lysis buffer
and sonicated on ice using a sonicator (UR-20P, TOMY, Tokyo,
Japan) 3 times for 20 sec each time. Genomic DNA was sheared
to 300 to 1200 base pairs of length. Chromatin solution from 1
610
6 cells/dish was preincubated with salmon sperm DNA and
Protein A-agarose and incubated with species-matched IgG or
with specific antibodies overnight at 4uC. DNA fragments
immunoprecipitated were then used as templates for PCR with
Ex taq (TaKaRa Bio, Kyoto, Japan) and reacted for 1 min at
94uC, 0.5 min at 94uC, 0.5 min at 72uC and 24 cycles of 30 sec
at 72uC. Nucleotide sequences of oligonucleotide used for real-
time PCR primers were as follows: ChmLDLR1-F: 59-
TCTGTGGGAGGAATTTGAGG-39, ChmLDLR1-R: 59-
GTACTAGGGGCGAGGTTTCC-39, ChmLDLR2-F: 59-
GTGTGGTGCAGGCCTTTAAT-39, and ChmLDLR2-R: 59-
CCATCGTTGCTGGCTAGTTT-39.
Western Blotting and Antibodies
To examine the expression levels of proteins in cells, proteins
were extracted from cells or mouse livers with a buffer containing
150 mM NaCl, 1 mM EDTA, 20 mM Tris (pH 8.0) and 0.5%
NP-40. Proteins were then separated on a 12.5% polyacrylamide
gel and subjected to Western blotting with respective antibodies.
Proteins on the membrane were reacted with an IRDye 800-
(Rockland, Philadelphia, PA, USA) or Alexa Fluor 680-conjugated
secondary antibody (Molecular Probes, Eugene, OR, USA) and
visualized by using an infrared imaging system (Odyssey, LI-COR,
Lincoln, NE, USA). Antibodies used were anti-HA (1:2000, MBL,
Nagoya Japan), anti-SREBP-1 (1:1000, Thermo Scientific, Wal-
tham, MA, USA), anti-SREBP-2 (1:1000, Abcam, Cambridge,
UK), anti-actin (1:4000, Chemicon, Temecula, CA, USA), anti-
DJ-1 (1:4000) and anti-LDLR (1:1000, Abcam) antibodies. The
rabbit anti-DJ-1 antibody was established by us as described
previously [1].
Gel-mobility Shift Assay
Gel mobility shift assays were carried out as described
previously [66]. Briefly, a reaction mixture containing 10 mgo f
NIH3T3 cell nuclear extract, 2 mg/ml poly(dG–dC), 100 mg/ml
bovine serum albumin, 16 mM Hepes (pH 7.9), 50 mM KCl,
4 mM EDTA, 0.8 mM DTT, 0.06% NP-40, 6% Ficoll 400 and
an IRDye800-conjugated probe was incubated for 30 min at
4uC. DNA–protein complexes formed in the mixture were
separated in a 4.5% polyacrylamide gel containing 0.256 TBE
and visualized by an infrared imaging system (Odyssey, LI-
COR). For a supershift experiment, the nuclear extract was first
incubated with the IRDye800-conjugated probe as described
above and then incubated with 1 mg of anti-DJ-1, anti-SREBP-1
(Thermo Scientific) and anti-SREBP-2 (Abcam) antibodies or
non-specific IgG for 30 min at 4uC. Nucleotide sequences of
oligonucleotides used for probes were as follows: SRE-EMSAs:
59- GGGAAAATCACCCCATTGC-39, mSRE-EMSAas: 59-
GGGAGCAATGGGGTGATTT-39, mSREm-EMSAs: 59-
GGGAAATCGATGGATATGC-39, and mSREm-EMSAas: 59-
GGGAGCATATCCATCGATT-39.
Co-immunoprecipitation Assay
Proteins were extracted from cultured cells by the procedure
described previously [13]. Proteins were immunoprecipitated with
a rabbit anti-DJ-1 antibody (1:500) or normal IgG and precipitates
were analyzed by Western blotting with anti-SREBP-1 (1:1000,
Thermo Scientific), anti-SREBP-2 (1:1000, Abcam) or mouse anti-
DJ-1 antibody (1:1000, 3E8, MBL). Proteins on membranes were
visualized as described above.
Indirect Immunofluorescence
Mouse liver cells were fixed with 4% paraformaldehyde for
15 min and then with 0.1% Triton X-100 for 10 min, and reacted
with an anti-LDLR antibody (1:100, abcam) or with an anti-DJ-1
antibody (1:500) for 2 hrs. The cells were then reacted with an
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anti-rabbit IgG for 1 hr, and their nuclei were stained with DAPI.
The cells were then observed under a fluorescent microscope
(Biorevo BZ-9000, Keyence, Osaka, Japan).
Tissue Preparation and Immunohistochemistry
Mice were perfused through the aorta with 1x PBS and then
with a cold fixative consisting of 4% paraformaldehyde in PBS.
After perfusion, the liver was quickly removed and post-fixed for
overnight with 4% paraformaldehyde in PBS and then transferred
to 10%, 20% and then 30% sucrose in PBS at 4uC for overnight.
The liver pieces were cut into 10-mm-thick slices using a cryostat.
Liver slices were treated with 0.1% Triton X-100 in PBS for
30 min and reacted with an anti-LDLR antibody (1:100, abcam)
or with an anti-DJ-1 antibody (1:100) for 4 days at room
temperature. After several washes, sections were reacted with an
FITC-conjugated anti-rabbit IgG for 2 hrs at room temperature.
The sections were also reacted with DAPI. Stained images were
then observed under a fluorescent microscope (Biorevo BZ-9000).
Measurement of Amounts of Total Cholesterol and LDL
Cholesterol in Serum from Mice
After DJ-1-kockout mice and normal mice had been fasted for
14 hrs, they were killed and their serum was obtained. Amounts of
total cholesterol and LDL cholesterol in serum were measured
using cholesterol E and LDL-C.M. kits (Wako Pure Chemicals,
Kyoto, Japan), respectively, according to manufacturer’s protocol.
For administration of estrogen to DJ-1-kockout mice and normal
mice, mice were subcutaneously injected with 5 mg/g body weight
of estradiol dissolved in propylene glycol for every 6 days. After
mice had been fasted for 15 hrs, LDL cholesterol in serum was
measured. To examine the effect of high-fat diets, wild-type and
DJ-1-kockout male mice at 13 weeks of age were fed with a high-
cholesterol diet (D12336, Research Diets, Inc.), and their serum
LDL cholesterol levels were measured as described above.
Statistical Analyses
Data are expressed as means 6 S.D or 6 S.E for mouse
experiments. Statistical analyses were performed using analysis of
variance (one-way ANOVA) followed by unpaired Student’s t-test.
For comparison of multiple samples, the Tukey-Kramer test was
used.
Supporting Information
Figure S1 Association of DJ-1 and SREBP with the LDLR
promoter. Chromatin immunoprecipitation assays were carried
out using chromatin prepared from NIH3T3 (A) and D2 (B) cells
as described in Figure 5. Aliquots of immunoprecipitated DNA
were separated on 1.4% agarose gels and stained by ethidium
bromide.
(PDF)
Figure S2 No direct binding of DJ-1 to SREBP-1 and
SREBP-2.
35S-labeled SREBP-1 and SREBP-2 were synthesized
in vitro using the reticulocyte lysate of the TNT transcription-
translation coupled system (Promega, Madison, WI). Labeled
proteins were mixed with GST or GST-DJ-1 expressed in and
prepared from Escherichia coli at 4uC for 60 min in a buffer
containing 150 mM NaCl, 5 mM EDTA, 50 mM Tris (pH 7.5),
0.05% bovine serum albumin, and 0.1% Nonidet P-40 (NP-40).
After washing with the same buffer, the bound proteins were
separated in a 10% polyacrylamide gel containing SDS and
visualized by fluorography.
(PDF)
Figure S3 No direct binding of DJ-1 to the SRE. Gel-
mobility shift assays were carried out using nuclear extracts from
SH-SY5Y cells and various amounts of purified human DJ-1 with
IRDye800-labeled SRE as a probe.
(PDF)
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